Lysophospholipids increase interleukin-8 expression in ovarian cancer cells.

No abstract is available for this paper.

• Publication year

  2001

• Venue

  Gynecologic Oncology

• Publication date

  2001-05-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1006/GYNO.2001.6124PMID 11330965
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Electrospray ionization mass spectrometry analysis of lysophospholipids in human ascitic fluids: comparison of the lysophospholipid contents in malignant vs nonmalignant ascitic fluids.

  2001cited by this paper
• Constitutive and lysophosphatidic acid (LPA)-induced LPA production: role of phospholipase D and phospholipase A2.

  2000cited by this paper
• Transfection of interleukin-8 increases angiogenesis and tumorigenesis of human gastric carcinoma cells in nude mice

  1999cited by this paper
• Sphingosine‐1‐phosphate modulates growth and adhesion of ovarian cancer cells

  1999cited by this paper
• Angiogenic activity and interleukin-8 content of human ovarian cancer ascites.

  1998cited by this paper
• The chemotactic cytokine interleukin-8--a cyst fluid marker for malignant epithelial ovarian cancer?

  1998cited by this paper
• Lysophosphatidic acid as a potential biomarker for ovarian and other gynecologic cancers.

  1998cited by this paper
• Biological therapy of ovarian cancer: current directions.

  1998cited by this paper
• Phorbol 12-myristate 13-acetate stimulates lysophosphatidic acid secretion from ovarian and cervical cancer cells but not from breast or leukemia cells.

  1998cited by this paper
• Expression of angiogenesis-related genes and progression of human ovarian carcinomas in nude mice.

  1998cited by this paper
• Human ovarian cancer of the surface epithelium.

  1997cited by this paper
• Growth factors in human ovarian cancer.

  1997cited by this paper
• Coexpression of interleukin-8 receptors in head and neck squamous cell carcinoma.

  1997cited by this paper
• Zytokinspiegel im malignen Aszites und peripheren Blut von Patientinnen mit fortgeschrittenem Ovarialkarzinom

  1996cited by this paper
• Interleukin 8 as a novel target for intervention therapy in acute inflammatory diseases.

  1996cited by this paper
• Tumor-host interaction: analysis of cytokines, growth factors, and tumor-infiltrating lymphocytes in ovarian carcinomas.

  1996cited by this paper
• -Cytokine level in malignant ascites and peripheral blood of patients with advanced ovarian carcinoma-.

  1996cited by this paper
• Inhibition of interleukin-8 reduces tumorigenesis of human non-small cell lung cancer in SCID mice.

  1996cited by this paper
• Characterization of human ovarian surface epithelial cells immortalized by human papilloma viral oncogenes (HPV-E6E7 ORFs).

  1995cited by this paper
• Lysophospholipids activate ovarian and breast cancer cells.

  1995cited by this paper
• Characterization of an ovarian cancer activating factor in ascites from ovarian cancer patients.

  1995cited by this paper
• Expression of interleukin 8 correlates with the metastatic potential of human melanoma cells in nude mice.

  1994cited by this paper
• Interleukin-8 as a macrophage-derived mediator of angiogenesis.

  1992cited by this paper
• Establishment and characterization of a new human cell line derived from ovarian clear cell carcinoma.

  1990cited by this paper
• Ascitic fluid from human ovarian cancer patients contains growth factors necessary for intraperitoneal growth of human ovarian adenocarcinoma cells.

  1990cited by this paper
• A putative new growth factor in ascitic fluid from ovarian cancer patients: identification, characterization, and mechanism of action.

  1988cited by this paper
• Comparative properties of five human ovarian adenocarcinoma cell lines.

  1985cited by this paper

• Impact of tumor necrosis factor‐alpha and lysophosphatidic acid on the behavior of ovarian cancer cells in a three‐dimensional collagen hydrogel

  2025cites this paper
• The lysophosphatidic acid-regulated signal transduction network in ovarian cancer cells and its role in actomyosin dynamics, cell migration and entosis

  2023cites this paper
• Influence of the autotaxin-lysophosphatidic acid axis on cellular function and cytokine expression in different breast cancer cell lines

  2022cites this paper
• Potential Role of Sphingolipidoses-Associated Lysosphingolipids in Cancer

  2022cites this paper
• Malignant Ascites in Ovarian Cancer: Cellular, Acellular, and Biophysical Determinants of Molecular Characteristics and Therapy Response

  2021cites this paper
• Lysophosphatidic Acid Signaling in Cancer Cells: What Makes LPA So Special?

  2021cites this paper
• Lysophosphatidic acid induces tumor necrosis factor‐alpha to regulate a pro‐inflammatory cytokine network in ovarian cancer

  2020cites this paper
• Sphingosine-1-phosphate (S1P) in ovarian physiology and disease.

  2019cites this paper
• Targeting Lysophosphatidic Acid in Cancer: The Issues in Moving from Bench to Bedside

  2019cites this paper
• Regulation of tumor cell - Microenvironment interaction by the autotaxin-lysophosphatidic acid receptor axis.

  2019cites this paper
• Bioactive lysolipids in cancer and angiogenesis.

  2019cites this paper
• Role of Sphingosylphosphorylcholine in Tumor and Tumor Microenvironment

  2019cites this paper
• The Role of Inflammation and Inflammatory Mediators in the Development, Progression, Metastasis, and Chemoresistance of Epithelial Ovarian Cancer

  2018cites this paper
• Cell type‐selective pathways and clinical associations of lysophosphatidic acid biosynthesis and signaling in the ovarian cancer microenvironment

  2018influential citation
• Sphingolipid metabolism and drug resistance in ovarian cancer

  2018cites this paper
• Novel effects of sphingosylphosphorylcholine on the apoptosis of breast cancer via autophagy/AKT/p38 and JNK signaling

  2018cites this paper
• Lysophospholipid Signaling in the Epithelial Ovarian Cancer Tumor Microenvironment

  2018cites this paper
• Sphingosine kinase 1/sphingosine-1-phosphate (S1P)/S1P receptor axis is involved in ovarian cancer angiogenesis

  2017cites this paper
• The role of sphingosine 1-phosphate in neutrophil trans-migration

  2016cites this paper
• Sphingolipids in spinal cord injury.

  2016influential citation
• Angiogenic effect of lysophosphatidic acid receptors on cervical cancer cells

  2015cites this paper
• Sphingosine 1-phosphate regulates IL-8 expression and secretion via S1PR1 and S1PR2 receptors-mediated signaling in extravillous trophoblast derived HTR-8/SVneo cells.

  2015cites this paper
• Review Article Sphingosylphosphorylcholine in cancer progress

  2015cites this paper
• Lysophosphatidic acid signaling in ovarian cancer

  2015cites this paper
• Sphingosylphosphorylcholine in cancer progress.

  2015cites this paper
• LPA Promotes T Cell Recruitment through Synthesis of CXCL13

  2015cites this paper
• New extracellular factors in glioblastoma multiforme development: neurotensin, growth differentiation factor-15, sphingosine-1-phosphate and cytomegalovirus infection

  2015cites this paper
• Lysophosphatidic acid-induced IL-8 secretion involves MSK1 and MSK2 mediated activation of CREB1 in human fibroblast-like synoviocytes.

  2014cites this paper
• Induction of chemokine (C-C motif) ligand 2 by sphingosine-1-phosphate signaling in neuroblastoma.

  2014cites this paper
• Ovarian cancer microenvironment: implications for cancer dissemination and chemoresistance acquisition

  2014cites this paper
• Lysophosphatidic Acid Enhanced the Angiogenic Capability of Human Chondrocytes by Regulating Gi/NF-kB-Dependent Angiogenic Factor Expression

  2014cites this paper
• Sphingosine 1-phosphate: A Potential Molecular Target for Ovarian Cancer Therapy?

  2014influential citation
• Atlas of Genetics and Cytogenetics in Oncology and Haematology LPAR 2 ( lysophosphatidic acid receptor 2 )

  2013cites this paper
• Sphingosin 1-phosphate contributes in tumor progression.

  2013cites this paper
• Lysophospholipid Signaling in Female and Male Reproductive Systems

  2013cites this paper
• LPAR2 (lysophosphatidic acid receptor 2)

  2013cites this paper
• Optimizing Molecular-Targeted Therapies in Ovarian Cancer: The Renewed Surge of Interest in Ovarian Cancer Biomarkers and Cell Signaling Pathways

  2012cites this paper
• Lysophosphatidic acid induces lymphangiogenesis and IL-8 production in vitro in human lymphatic endothelial cells.

  2012cites this paper
• Insights into the pharmacological relevance of lysophospholipid receptors

  2012cites this paper
• LPA Stimulates the Phosphorylation of p130Cas via Gαi2 in Ovarian Cancer Cells.

  2012cites this paper
• Lysophosphatidic acid receptor 2/3‐mediated IL‐8‐dependent angiogenesis in cervical cancer cells

  2012cites this paper
• Transcriptomic Analysis of Human Ovarian Cancer Cells: Changes Mediated by Luteinizing Hormone Receptor Activation

  2012cites this paper
• Lysophosphatidic acid activates TGFBIp expression in human corneal fibroblasts through a TGF-β1-dependent pathway.

  2012cites this paper
• Regulation of gene expression in ovarian cancer cells by luteinizing hormone receptor expression and activation

  2011cites this paper
• Proteomic Identification of Betaig-h3 as a Lysophosphatidic Acid-Induced Secreted Protein of Human Mesenchymal Stem Cells: Paracrine Activation of A549 Lung Adenocarcinoma Cells by Betaig-h3*

  2011cites this paper
• The NF-κB pathway mediates lysophosphatidic acid (LPA)-induced VEGF signaling and cell invasion in epithelial ovarian cancer (EOC).

  2011influential citation
• LPA5 Is Abundantly Expressed by Human Mast Cells and Important for Lysophosphatidic Acid Induced MIP-1β Release

  2011cites this paper
• Connective Tissue Growth Factor (CTGF/CCN2) Mediates Angiogenic Effect of S1P in Human Dermal Microvascular Endothelial Cells

  2011cites this paper
• Comparison of total plasma lysophosphatidic acid and serum CA-125 as a tumor marker in the diagnosis and follow-up of patients with epithelial ovarian cancer.

  2010cites this paper
• Lysophosphatidic Acid Inhibits CC Chemokine Ligand 5/RANTES Production by Blocking IRF-1–Mediated Gene Transcription in Human Bronchial Epithelial Cells

  2010cites this paper
• Epithelial Transcription in Human Bronchial Mediated Gene - by Blocking IRF-1 Chemokine Ligand 5/RANTES Production Lysophosphatidic Acid Inhibits CC

  2010cites this paper
• Cytoreductive surgery: Upper abdomen-left hypochondriac and epigastric regions

  2010cites this paper
• Lysophosphatidic acid stimulates cell migration, invasion, and colony formation as well as tumorigenesis/metastasis of mouse ovarian cancer in immunocompetent mice

  2009cites this paper
• Lysophosphatidic Acid-Induced Transcriptional Profile Represents Serous Epithelial Ovarian Carcinoma and Worsened Prognosis

  2009influential citation
• Roles of LPA in ovarian cancer development and progression.

  2009cites this paper
• Fasudil Inhibits Lysophosphatidic Acid-Induced Invasiveness of Human Ovarian Cancer Cells

  2009cites this paper
• Local effects of the sphingosine 1‐phosphate on prostaglandin F2alpha‐induced luteolysis in the pregnant rat

  2009cites this paper
• LPA receptor 2 mediates LPA-induced endometrial cancer invasion.

  2009cites this paper
• Lysophosphatidic acid and invasion.

  2009cites this paper
• Subtype-specific Residues Involved in Ligand Activation of the Endothelial Differentiation Gene Family Lysophosphatidic Acid Receptors*

  2008cites this paper
• Lysophosphatidic acid activates telomerase in ovarian cancer cells through hypoxia‐inducible factor‐1α and the PI3K pathway

  2008influential citation
• S 1 P differentially regulates migration of human ovarian cancer and human ovarian surface epithelial cells

  2008cites this paper
• BIOLOGICAL FUNCTIONS OF THE NOVEL LYSOPHOSPHATIDIC ACID (LPA) RECEPTOR, LPA 4 /p2y9/GPR23

  2008cites this paper
• Lysophosphatidic acid induces ovarian cancer cell dispersal by activating Fyn kinase associated with p120‐catenin

  2008cites this paper
• Protein Kinase C-ϵ Regulates Sphingosine 1-Phosphate-mediated Migration of Human Lung Endothelial Cells through Activation of Phospholipase D2, Protein Kinase C-ζ, and Rac1*

  2008cites this paper
• Protein kinase C alpha-CARMA3 signaling axis links Ras to NF-kappa B for lysophosphatidic acid-induced urokinase plasminogen activator expression in ovarian cancer cells.

  2008cites this paper
• Lysophosphatidic acid receptors determine tumorigenicity and aggressiveness of ovarian cancer cells.

  2008cites this paper
• Lysophospholipid signaling in the function and pathology of the reproductive system.

  2008cites this paper
• S1P differentially regulates migration of human ovarian cancer and human ovarian surface epithelial cells

  2008cites this paper
• The lysophosphatidic acid (LPA) receptors their expression and significance in epithelial ovarian neoplasms.

  2007cites this paper
• Lysophosphatidic acid downregulates tissue inhibitor of metalloproteinases, which are negatively involved in lysophosphatidic acid-induced cell invasion

  2007cites this paper
• Role of Lysophospholipids in Cell Growth and Survival

  2007cites this paper
• The regulation of cellular trafficking of the human lysophosphatidic acid receptor 1: Identification of the molecular determinants required for receptor trafficking

  2007cites this paper
• Protein kinase Cα-CARMA3 signaling axis links Ras to NF-κB for lysophosphatidic acid-induced urokinase plasminogen activator expression in ovarian cancer cells

  2007cites this paper
• SPARC inhibits LPA-mediated mesothelial-ovarian cancer cell crosstalk.

  2007cites this paper
• Inhibition of Matrilysin Expression by Antisense or RNA Interference Decreases Lysophosphatidic Acid–Induced Epithelial Ovarian Cancer Invasion

  2006cites this paper
• Lysophosphatidic acid (LPA)-induced vascular endothelial growth factor (VEGF) by mesothelial cells and quantification of host-derived VEGF in malignant ascites.

  2006cites this paper
• The G12/13-RhoA signaling pathway contributes to efficient lysophosphatidic acid-stimulated cell migration

  2006cites this paper
• Hypoxia enhances lysophosphatidic acid responsiveness in ovarian cancer cells and lysophosphatidic acid induces ovarian tumor metastasis in vivo.

  2006cites this paper
• Of Spiders and Crabs: The Emergence of Lysophospholipids and Their Metabolic Pathways as Targets for Therapy in Cancer

  2006cites this paper
• Lysophosphatidic acid is constitutively produced by human peritoneal mesothelial cells and enhances adhesion, migration, and invasion of ovarian cancer cells.

  2006cites this paper
• Ovarian Cancer α Growth-Regulated Oncogene Lysophosphatidic Acid Is a Major Regulator of Updated

  2006cites this paper
• Lysophosphatidic acid is a major regulator of growth-regulated oncogene alpha in ovarian cancer.

  2006cites this paper
• Validation of an anti-sphingosine-1-phosphate antibody as a potential therapeutic in reducing growth, invasion, and angiogenesis in multiple tumor lineages.

  2006cites this paper
• Lysophospholipids increase IL‐8 and MCP‐1 expressions in human umbilical cord vein endothelial cells through an IL‐1‐dependent mechanism

  2006cites this paper
• Lysophosphatidic Acid Is a Major Regulator of Growth-Regulated Oncogene α in Ovarian Cancer

  2006cites this paper
• Lipid phosphate phosphatase-1 regulates lysophosphatidic acid-induced calcium release, NF-kappaB activation and interleukin-8 secretion in human bronchial epithelial cells.

  2005cites this paper
• A requirement for membrane cholesterol in the β-arrestin- and clathrin-dependent endocytosis of LPA1 lysophosphatidic acid receptors

  2005cites this paper
• Signaling Mechanisms Responsible for Lysophosphatidic Acid-induced Urokinase Plasminogen Activator Expression in Ovarian Cancer Cells*

  2005cites this paper
• Chapter 18 – Multiplexed Serum Assays

  2005cites this paper
• Functional lipidomics: Lysophosphatidic acid as a target for molecular diagnosis and therapy of ovarian cancer

  2005cites this paper
• Cyclooxygenase-2 functions as a downstream mediator of lysophosphatidic acid to promote aggressive behavior in ovarian carcinoma cells.

  2005cites this paper
• Protein kinase A inhibits lysophosphatidic acid induction of serum response factor via alterations in the actin cytoskeleton.

  2004cites this paper
• Protein kinase Cdelta mediates lysophosphatidic acid-induced NF-kappaB activation and interleukin-8 secretion in human bronchial epithelial cells.

  2004cites this paper
• Lysophosphatidic acid enhances epithelial ovarian carcinoma invasion through the increased expression of interleukin-8.

  2004cites this paper
• Evidence for tight coupling of Gi protein-mediated lysophosphatidic acid receptor to stimulated cytokine production in ovarian cancer cell.

  2004cites this paper
• Over-expression of lysophosphatidic acid receptor-2 in human invasive ductal carcinoma

  2004cites this paper
• Modulation of adpative immune responses by sphingosine-1-phosphate

  2004cites this paper
• Mechanisms for Lysophosphatidic Acid-induced Cytokine Production in Ovarian Cancer Cells*

  2004cites this paper
• Protein Kinase Cδ Mediates Lysophosphatidic Acid-induced NF-κB Activation and Interleukin-8 Secretion in Human Bronchial Epithelial Cells*

  2004cites this paper